Structure-activity relationships of quassinoids for eukaryotic protein synthesis

Cancer Letters

Volumn 220, Issue 1, 2005, Pages 37-48

  Fukamiya, Narihiko ^a   Lee, Kuo Hsiung ^b   Muhammad, Ilias ^c   Murakami, Chihiro ^a   Okano, Masayohis ^a   Harvey, Isabelle ^d   Pelletier, Jerry ^d,e  

^a HIROSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Protein synthesis inhibitor; Quassinoid; Structure activity relationships; Translation

Indexed keywords

AILANTHONE; ANTINEOPLASTIC AGENT; BRUCEANOL A; BRUCEANOL B; BRUCEANOL C; BRUCEANOL D; BRUCEANOL E; BRUCEANTIN; BRUCEANTINOSIDE A; BRUCEOSIDE A; BRUCEOSIDE G; BRUSATOL; CHAPARRIN; DEHYDROBRUCEANTARIN; DEHYDROBRUCENTIN; ISOBRUCEIN B; QUASSINOID DERIVATIVE; SEMALIKALACTONE D; SERGEOLIDE; SINJULACTONE B; SINJULACTONE C; UNCLASSIFIED DRUG; UNINDEXED DRUG; YADANZIOSIDE A; YADANZIOSIDE C; YADANZIOSIDE D; YADANZIOSIDE E; YADANZIOSIDE G; YADANZIOSIDE L; YADANZIOSIDE M; YADANZIOSIDE N;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES; EUKARYOTE; HELA CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION; TRANSLATION REGULATION;

EID: 14644401085     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.04.023     Document Type: Article

References (40)

1. S.J. Watkins, and C.J. Norbury Translation initiation and its deregulation during tumorigenesis Br. J. Cancer 86 2002 1023 1027
2. J.R. Graff, and S.G. Zimmer Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs Clin. Exp. Met. 20 2003 265 273
3. J.W.B. Hershey, and S. Miyamoto Translational control and cancer N. Sonenberg J.W.B. Hershey M.B. Mathews Translational Control of Gene Expression 2000 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY 637 654
4. N. Anand, S. Murthy, G. Amann, M. Wernick, L.A. Porter, I.H. Cukier, C. Collins, J.W. Gray, J. Diebold, D.J. Demetrick, and J.M. Lee Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer Nat. Genet. 31 2002 301 305
5. N. Tarbe, V. Evtimova, H. Burtscher, M. Jarsch, F. Alves, and U.H. Weidle Transcriptional profiling of cell lines derived from an orthotopic pancreatic tumor model reveals metastasis-associated genes Anticancer Res. 21 2001 3221 3228
6. N. Draptchinskaia, P. Gustavsson, B. Andersson, M. Pettersson, T.N. Willig, I. Dianzani, S. Ball, G. Tchernia, J. Klar, H. Matsson, D. Tentler, N. Mohandas, B. Carlsson, and N. Dahl The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia Nat. Genet. 21 1999 169 175
7. A.H. Cavanaugh, W.M. Hempel, L.J. Taylor, V. Rogalsky, G. Todorov, and L.I. Rothblum Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product Nature 374 1995 177 180
8. S. Ciarmatori, P.H. Scott, J.E. Sutcliffe, A. McLees, H.M. Alzuherri, J.H. Dannenberg, H. Te Riele, I. Grummt, R. Voit, and R.J. White Overlapping functions of the pRb family in the regulation of rRNA synthesis Mol. Cell. Biol. 21 2001 5806 5814
9. D. Ruggero, and P.P. Pandolfi Does the ribosome translate cancer? Nat. Rev. 3 2003 179 192
10. F. Meric, and K.K. Hunt Translation Initiation in Cancer: A Novel Target for Therapy Mol. Cancer Ther. 1 2003 971 979
11. M. Holcik, and R.G. Korneluk Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation Mol. Cell. Biol. 20 2000 4648 4657
12. H.-G. Wendel, E. de Stanchina, J.S. Fridman, A. Malina, S. Ray, S. Kogan, C. Cordon-Cardo, J. Pelletier, and S.W. Lowe Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy Nature 428 2004 332 337
13. S.M. Kupchan, R.W. Britton, M.F. Ziegler, and C.W. Sigel Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica J. Org. Chem. 38 1973 178 179
14. S.M. Kupchan, R.W. Britton, J.A. Lacadie, M.F. Ziegler, and C.W. Sigel The isolation and structural elucidation of bruceatin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica J. Org. Chem. 40 1975 648 654
15. A. Pierré, M. Robert-Géro, C. Tempête, and J. Polonsky Structural requirements of quassinoids for the inhibition of cell transformation Biochem. Biophys. Res. Commun. 93 1980 675 686
16. P.Y. Guru, D.C. Warhurst, A. Harris, and J.D. Phillipson Antimalaria activity of bruceantin in vitro Ann. Trop. Med. Parasit. 77 1983 433 435
17. L.-L. Liao, S.M. Kupchan, and S.B. Horwitz Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis Mol. Pharm. 12 1976 167 176
18. M. Fresno, A. Gonzales, D. Vazquez, and A. Jimenez Bruceantin, a novel inhibitor of peptide formation Biochim. Biophys. Acta 518 1978 104 112
19. W. Willingham Jr., R.T. Considine, S.G. Chaney, K.-H. Lee, and I.H. Hall Reversibility of protein synthesis inhibition by quassinoid antineoplastic agents in a rabbit reticulocyte system Biochem. Pharm. 33 1981 330 333
20. Y.F. Liou, I.H. Hall, M. Okano, K.-H. Lee, S.G. Chaney, and S.G. Antitumor Agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism J. Pharm. Sci. 71 1982 430 435
21. R.T. Considine, W. Willingham Jr., S.G. Chaney, S. Wyrick, I.H. Hall, and K.-H. Lee Structure-activity relationships for binding and inactivation of rabbit reticulocyte ribosomes by quassinoid antineoplastic agents Eur. J. Biochem. 132 1983 157 163
22. C. Rodriguez-Fonseca, R. Amils, and R.A. Garrett Fine structure of the peptidyl transferase centre on 23S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes J. Mol. Biol. 247 1995 224 235
23. A. Jimenez, and D. Vazquez Quantitative binding of antibiotics to ribosomes from a yeast mutant altered on the peptidyl-transferase center Eur. J. Biochem. 54 1975 483 492
24. E. Mata-Greenwood, M. Cuendet, D. Sher, D. Gustin, W. Stock, and J.M. Pezzuto Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc Leukemia 16 2002 2275 2284
25. M. Cuendet, and J.M. Pezzuto Antitumor activity of bruceantin: an old drug with new promise J. Nat. Prod. 67 2004 269 272
26. M. Cuendet, J.J. Gills, and J.M. Pezzuto Brusatol-induced HL-60 cell differentiation involves NF-kB activation Cancer Lett. 206 2004 43 50
27. J. Liesmann, R.J. Belt, C.D. Haas, and B. Hoogstraten Phase I study on bruceantin administered on a weekly schedule Cancer Treat. Rep. 65 1981 883 885
28. A.Y. Bedikian, M. Valdivieso, G.P. Bodey, W.K. Murphy, and E.J. Freireich Initial clinical studies with bruceantin Cancer Treat. Rep. 63 1979 1843 1847
29. C.L. Wiseman, H.Y. Yap, A.Y. Bedikian, G.P. Bodey, and G.R. Blumenschein Phase II trial of bruceantin in metastatic breast carcinoma Am. J. Clin. Oncol. 5 1982 389 391
30. J.C. Arseneau, J.M. Wolter, M. Kuperminc, and J.C. Ruckdeschel A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma Invest. New Drugs 1 1983 239 242
31. J. Sambrook, and D.W. Russell Molecular Cloning. A laboratory Manual 2001 Cold Spring Harbor laboratory Press Cold Spring Harbor, NY
32. M. Okana, N. Fukamiya, and K.H. Lee A. Rahman Biologically active compounds from Simaroubaceous plants Studies in Natural Products Chemistry vol. 7 1990 Elsevier Amsterdam 369 404
33. M. Okano, N. Fukamiya, and K.H. Lee A. Rahman Bioactive quassinoids Studies in Natural Products Chemistry vol. 23 2000 Elsivier Amsterdam 285 333
34. O. Novac, A.-S. Guenier, and J. Pelletier Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen Nucl. Acids Res. 32 2004 902 915
35. Y.V. Svitkin, and N. Sonenberg D.R. Schoenberg An efficient system for cap- and poly A -dependent translation in vitro mRNA Processing and Metabolism 2004 Humana Totowa, NJ 155 170
36. I.H. Hall, K.-H. Lee, S.A. Eigebaly, Y. Imakura, Y. Sumida, and R.Y. Wu Antitumor agents XXXIV: Mechanism of action of bruceoside A and brusatol on nucleic acid metabolism of P-388 lymphocytic leukemia cells J. Pharm. Sci. 68 1979 883 887
37. K.-H. Lee, M. Okano, I.H. Hall, D.A. Brent, and B. Soltmann Antitumor agents XKV: Bisbrusatolyl and brusatolyl esters and related compounds as novel potent antileukemic agents J. Pharm. Sci. 71 1982 338 345
38. I.H. Hall, Y.F. Liou, M. Okano, and K.-H. Lee Antitumor agents XLVI: In vitro effects of esters of brusatol, bisbrusatol, and related compounds on nucleic acid and protein synthesis of P-388 lymphocytic leukemia cells J. Pharm. Sci. 71 1982 345 348
39. E. Mata-Greenwood, J.F. Daeuble, P.A. Grieco, J. Dou, J.D. McChesney, R.G. Mehta, D. Kinghorn, and J.M. Pezzuto Novel esters of glaucarubolone as inducers of terminal differentiation of promyelocytic HL-60 cells and inhibitors of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesion formation in mouse mammary organ culture J. Nat. Prod. 64 2001 1509 1513
40. M.J. O'Neill, D.H. Bray, P. Boardman, J.D. Phillipson, D.C. Warhurst, W. Peters, and M. Suffness Plants as sources of antimalaria drugs: In vitro antimalarial activities of some quassinoids Antimicro. Agents Chemother. 30 1986 101 104